Skip to main content

Table 1 Characteristics of subgroups based on the presence of sICH

From: Hypersensitive C-reactive protein-albumin ratio predicts symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke patients

Variable sICH group (n=37) Non-sICH group (n=297) P
Demographic characteristics
 Age, years 73.2 ±10.9 68.5 ±11.2 0.016
 Male, % 23 (62.2) 187 (63.0) 0.904
Vascular risk factors, %
 Hypertension 32 (86.5) 197 (66.3) 0.014
 Diabetes mellitus 9 (24.3) 58 (19.5) 0.515
 Dyslipidemia 7 (18.9) 93 (31.3) 0.132
 Coronary heart disease 12 (32.4) 63 (21.2) 0.529
 Atrial fibrillation 14 (37.8) 85 (28.6) 0.076
 Previous stroke 9 (24.3) 70 (23.6) 0.100
 Current drinking 8 (21.6) 82 (27.6) 0.421
 Current smoking 9 (24.3) 102 (34.3) 0.144
Clinical data
 Previous antiplatelet, % 14 (37.8) 47 (15.8) 0.003
 SBP, mmHg 149.7 ±22.7 139.8 ±23.9 0.017
 DBP, mmHg 84.1 ±17.7 85.2 ±14.6 0.668
 Body mass index, kg/m2 24.2 ±3.8 24.1 ±3.7 0.919
 Initial NIHSS, score 16 (13, 22) 15 (11, 19) 0.043
 Intravenous thrombolysis, % 21 (56.8) 122 (41.1) 0.069
 Time from door to puncture, min 120.0 (90.5, 149.0) 110.0 (75.0, 140.0) 0.075
 Number of thrombectomy device passes 2 (1, 3) 2 (1, 3) 0.048
 Poor collateral status, % 23 (62.2) 135 (45.5) 0.055
 Successful recanalization, % 33 (89.2) 256 (86.2) 0.800
Stroke subtype, %    0.169
 LAA 12 (32.4) 139 (46.8)  
 CE 21 (56.8) 121 (40.7)  
 Other subtype 4 (10.8) 37 (12.5)  
Laboratory data
 TC, mmol/L 4.2 ±1.2 4.4 ±1.2 0.537
 TG, mmol/L 1.1 (0.8, 1.7) 1.1 (0.8, 1.6) 0.375
 LDL, mmol/L 2.6 (1.9, 3.2) 2.6 (2.0, 3.2) 0.469
 HDL, mmol/L 1.1±0.3 1.1±0.4 0.865
 FBG, mmol/L 9.0 ±3.5 6.9 ±2.4 0.001
 Homocysteine, μmol/L 12.8 (10.7, 16.0) 12.3 (10.4, 15.8) 0.588
 HAR, 10−3 0.54 (0.24, 1.55) 0.17 (0.09, 0.33) 0.001
  1. Abbreviation: NIHSS, National institute of health stroke scale, SBP Systolic blood pressure, DBP Diastolic blood pressure, LAA Large-artery atherosclerosis, CE Cardioembolism, TC Total cholesterol, TG Triglyceride, LDL Low-density lipoprotein, HDL High-density lipoprotein, FBG Fasting blood glucose, HAR Hypersensitive C-reactive protein-albumin ratio